Literature DB >> 2889490

The expression of N-methyl-D-aspartate-receptor-mediated component during epileptiform synaptic activity in hippocampus.

T J Ashwood1, H V Wheal.   

Abstract

1 The possible involvement of N-methyl-D-aspartate (NMDA)-receptors in epileptiform synaptic activity in the kainic acid (KA) lesioned hippocampus was investigated. In this chronic model of epilepsy there is a loss of both the early and the late components of synaptic inhibition as well as changes in the membrane properties of the surviving CA1 pyramidal cells. 2 The action of the specific NMDA-receptor antagonist D-2-amino-5-phosphonovalerate (D-APV) was tested on evoked bursts of action potentials recorded intracellularly from cells of lesioned hippocampi. The effects of D-APV on control synaptic responses from the contralateral, unlesioned hippocampi were also recorded. 3 In the presence of Mg2+ (1 mM), D-APV (20 microM) had a profound effect on the evoked epileptiform activity. Both the number of action potentials in the burst, as well as the area under the excitatory postsynaptic potential (e.p.s.p.) was considerably reduced. Furthermore this D-APV-sensitive component of the epileptiform burst had a very early onset, coincident with the first action potential in the burst. 4 D-APV (20 microM) was ineffective in blocking the e.p.s.p. evoked by Schaffer collateral afferents onto CA1 cells in slices of hippocampus contralateral to the KA lesion. 5 D-APV had no effect on the passive membrane properties of either population of cells. Hyperpolarizing potentials such as the inhibitory postsynaptic potentials (i.p.s.ps) or the afterhyperpolarization following a current-induced burst of action potentials were also unaffected. 6 It appears that an NMDA-receptor component is expressed during synaptically evoked epileptiform activity in this chronic model of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889490      PMCID: PMC1853572          DOI: 10.1111/j.1476-5381.1987.tb11280.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

2.  Anticonvulsant action of excitatory amino acid antagonists.

Authors:  M J Croucher; J F Collins; B S Meldrum
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

3.  A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices.

Authors:  C E Herron; R Williamson; G L Collingridge
Journal:  Neurosci Lett       Date:  1985-11-11       Impact factor: 3.046

4.  Epileptiform burst afterhyperolarization: calcium-dependent potassium potential in hippocampal CA1 pyramidal cells.

Authors:  B E Alger; R A Nicoll
Journal:  Science       Date:  1980-12-05       Impact factor: 47.728

5.  Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice.

Authors:  R Dingledine; M A Hynes; G L King
Journal:  J Physiol       Date:  1986-11       Impact factor: 5.182

6.  A calcium-activated hyperpolarization follows repetitive firing in hippocampal neurons.

Authors:  J R Hotson; D A Prince
Journal:  J Neurophysiol       Date:  1980-02       Impact factor: 2.714

7.  Intracellular demonstration of an N-methyl-D-aspartate receptor mediated component of synaptic transmission in the rat hippocampus.

Authors:  C E Herron; R A Lester; E J Coan; G L Collingridge
Journal:  Neurosci Lett       Date:  1985-09-16       Impact factor: 3.046

8.  A magnesium-sensitive post-synaptic potential in rat cerebral cortex resembles neuronal responses to N-methylaspartate.

Authors:  A M Thomson
Journal:  J Physiol       Date:  1986-01       Impact factor: 5.182

9.  Extracellular studies on the role of N-methyl-D-aspartate receptors in epileptiform activity recorded from the kainic acid-lesioned hippocampus.

Authors:  T J Ashwood; H V Wheal
Journal:  Neurosci Lett       Date:  1986-06-18       Impact factor: 3.046

10.  CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.

Authors:  J Davies; R H Evans; P L Herrling; A W Jones; H J Olverman; P Pook; J C Watkins
Journal:  Brain Res       Date:  1986-09-10       Impact factor: 3.252

View more
  6 in total

1.  Operative GABAergic inhibition in hippocampal CA1 pyramidal neurons in experimental epilepsy.

Authors:  M Esclapez; J C Hirsch; R Khazipov; Y Ben-Ari; C Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 2.  Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy.

Authors:  J G Tasker; F E Dudek
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

3.  Redox modulation of synaptic responses and plasticity in rat CA1 hippocampal neurons.

Authors:  C L Bernard; J C Hirsch; R Khazipov; Y Ben-Ari; H Gozlan
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

4.  A role for synaptic and network plasticity in controlling epileptiform activity in CA1 in the kainic acid-lesioned rat hippocampus in vitro.

Authors:  C Bernard; H V Wheal
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

5.  HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.

Authors:  Kelly A Krogh; Matthew V Green; Stanley A Thayer
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus.

Authors:  Pradeep Punnakkal; Deity Dominic
Journal:  Neuromolecular Med       Date:  2018-01-15       Impact factor: 3.843

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.